Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery

被引:0
|
作者
Bart, PA
Jacquier, P
Zuber, PLF
Lavanchy, D
Frei, PC
机构
[1] CHU VAUDOIS, DIV IMMUNOL & ALLERGY, CH-1011 LAUSANNE, SWITZERLAND
[2] UNIV BERN, INST PARASITOL, BERN, SWITZERLAND
[3] FED OFF PUBL HLTH, BERN, SWITZERLAND
来源
LIVER | 1996年 / 16卷 / 02期
关键词
HBV and HDV infection; isolated anti-HBe; seroprevalence; women at delivery;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Serum samples from 9006 women, who delivered in Switzerland in 1990 and 1991, were collected around the country. Of these women, 62.7% were Swiss and 37.3% originated from foreign countries. Samples were first screened for anti-HBc and those found positive were further tested for HBsAg, anti-HBs and anti-HDV. Anti-HBc was found in 640 of the 9006 women (overall prevalence, 7.1%; Swiss, 3.3%; foreigners, 13.5%). Of these 640 positive samples, 61 (9.5%) were positive for HBsAg (without anti-HBs), 467 (73.0%) positive for anti-HBs (without HBsAg) and 8 (1.3%) positive for both HBsAg and anti-HBs. The remaining 104 were thus anti-HBc positive without HBsAg or anti-HBs. These 104 specimens with the so-called ''isolated anti-HBc'' reactivity represented 1.2% of the whole population or 16.3% of the 640 anti-HBc positive mothers. All were HBV DNA negative (PCR). Anti-HDV antibody was found in only five women. HBsAg was seen in 38 of the cord-blood samples from the anti-HBc positive mothers. In this large sampling, we observed a relatively high seroprevalence of HBV infection. Cases with isolated anti-HBc reactivity, being HBV DNA negative by PCR, were probably non-infectious at the time of blood collection.
引用
收藏
页码:110 / 116
页数:7
相关论文
共 50 条
  • [1] Fatal HBV reactivation in a subject with anti-HBs and anti-HBc
    Umemura, Takeji
    Kiyosawa, Kendo
    INTERNAL MEDICINE, 2006, 45 (12) : 747 - 748
  • [2] Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs
    Kabir, Ali
    Keshvari, Maryam
    Kashani, Amir Hossein Faghihi
    Alavian, Seyed-Moayed
    HUMAN VACCINES, 2008, 4 (05): : 379 - 383
  • [3] INCIDENCE OF HBSAG, ANTI-HBS, ANTI-HBC AND ANTI-HAV IN LABORATORY PERSONNEL
    COMPTON, J
    GRIEP, J
    BONDERMAN, D
    CLINICAL CHEMISTRY, 1979, 25 (06) : 1081 - 1081
  • [4] ANTI-HBC AND ANTI-HBS IN HBSAG NEGATIVE CHRONIC LIVER-DISEASE
    KERLIN, P
    ASHCAVAI, M
    REDEKER, A
    PETERS, R
    JONES, M
    GASTROENTEROLOGY, 1979, 77 (05) : A22 - A22
  • [5] Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects
    Sünbül, M
    Leblebicioglu, H
    Esen, S
    Eroglu, C
    Barut, S
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2000, 32 (03) : 315 - 316
  • [6] SIGNIFICANCE OF ANTI-HBS AND ANTI-HBC AS IMMUNE STATUS MARKERS
    OVERBY, LR
    DECKER, R
    MUSHAHWAR, I
    DEVELOPMENTS IN BIOLOGICAL STANDARDIZATION, 1983, 54 : 141 - 142
  • [7] HBs Ag, Anti-HBs, Anti-HBc Total and Anti-HCV Seroprevalence of the Patients Applied to Beytepe Military Hospital
    Coban, Mehmet
    Sertoglu, Erdim
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2013, 19 (03): : 152 - 155
  • [8] HBSAG, ANTI-HBS, ANTI-HBC, AND ANTI-HA IN NON INSTITUTIONALIZED MENTALLY-RETARDED PATIENTS
    RENNER, F
    HORAK, W
    ANDRLE, M
    RETT, A
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1978, 10 (03): : 202 - 202
  • [9] HBSAG, ANTI-HBS, ANTI-HBC, AND ANTI-HAV IN COMMERCIAL LYOPHILIZED QUALITY-CONTROL SERA
    COMPTON, J
    BONDERMAN, D
    PROKSCH, G
    GRIEP, J
    CLINICAL CHEMISTRY, 1979, 25 (07) : 1347 - 1349
  • [10] SHOULD ANTI-HBS OR ANTI-HBC BE USED AS SCREENING-TEST
    TRIGER
    DEINHARDT, F
    THOMAS
    SHERLOCK, S
    KRUGMAN, S
    PAPAEVANGELOU, G
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1983, : 55 - 57